Secondary screening

Friday, 08 December, 2006 | Supplied by: http://www.invetech.com.au/

CellKey is a high information secondary screening instrument employing cellular dielectric spectroscopy (CDS).

The CellKey platform is a fully automated system for secondary screening laboratories and target validation. CellKey enables label-free and universal measurements of endogenous and transfected receptors, irrespective of their coupling mechanism. Kinetic measurements are taken in real time with all wells of the microplate being read in parallel.

Online: http://www.invetech.com.au/

MaxWell Biosystems MaxOne+ HD-MEA Chip

The MaxOne⁺ HD-MEA Chip provides an upgraded performance and user experience through...

Immundiagnostik ID-Vit MTP assays

Immundiagnostik's ID-Vit MTP assays range enables the quantification of all eight...

Bertin Bioreagent obesity research ELISA kits

Bertin Bioreagent's obesity research ELISA kits include targets for 20-hydroxyecdysone,...

Content from other channels on our network

Vic Government funding 11 manufacturers for defence supply chain

Meaningful connections: connectivity challenges in Australia's process automation landscape

NSW Government backs hydrogen safety research at UoW

Nozomi Networks and Schneider Electric embed security sensor in RTUs

Hysteresis in pressure calibration: what you need to know

Government to develop national food security strategy

Health Star Ratings voluntary phase nears end

Glass packaging initiative reduces carbon emissions

Rising milk output impacts global dairy values

Direct-to-can printing tech launches at Orora

Doctors at breaking point — can AI medical scribes help?

Explore the Future of Cleaning and Hygiene at ISSA Expo 2025

Does routine AI assistance erode endoscopy skills?

Transform from Security Awareness to a Security Culture: A Vital Shift for SMB Healthcare — Webinar

Using social prescribing as 'a script against loneliness'